Scientists say just 7 days of meditation can rewire your brain

A week of intensive meditation and other mind and body practices may be capable of producing measurable changes far beyond simple relaxation. In a recent study, researchers at the University of California San Diego found that a seven-day retreat was associated with changes in brain activity, blood chemistry, immune signaling, metabolism, and the body's natural pain control systems.

The researchers also found signs of increased neuroplasticity, which is the brain's ability to adapt, reorganize, and form new connections. The findings, published in Communications Biology, offer new clues about how mental practices and conscious experiences may influence physical biology.

Measuring the Biology of Meditation

Meditation and related practices have been used in cultures around the world for thousands of years as tools for health and well-being. Scientists, however, are still working to understand exactly what happens inside the brain and body when people engage in these practices.

The new research was part of a multi-million-dollar initiative supported by the InnerScience Research Fund. According to the researchers, it is the first study to comprehensively measure the biological effects of several mind and body practices delivered together during a short, intensive program.

"We've known for years that practices like meditation can influence health, but what's striking is that combining multiple mind-body practices into a single retreat produced changes across so many biological systems that we could measure directly in the brain and blood," said senior study author Hemal H. Patel, Ph.D., professor of anesthesiology at UC San Diego School of Medicine and research career scientist at the Veterans Affairs San Diego Healthcare System. "This isn't about just stress relief or relaxation; this is about fundamentally changing how the brain engages with reality and quantifying these changes biologically."

Inside the Seven-Day Retreat

The study involved 20 healthy adults who participated in a 7-day residential program led by neuroscience educator and author Joe Dispenza, D.C. The retreat included daily lectures, approximately 33 hours of guided meditation, and group healing practices.

Some of those healing activities relied on an "open-label placebo" approach. Unlike a traditional placebo, where participants may not know they are receiving an inactive treatment, people taking part in an open placebo know from the beginning that no active medical ingredient is involved. Researchers have studied this approach because expectations, social interaction, and the experience of participating in a treatment can sometimes produce measurable effects even when no active drug is given.

Before and after the retreat, scientists examined participants' brains using functional magnetic resonance imaging (fMRI). This type of scanning detects changes in blood flow associated with brain activity, allowing researchers to observe which areas and networks are more or less active.

Blood samples were also collected so the team could examine changes involving metabolism, immune activity, molecular signaling, and other biological processes.

Changes From the Brain to the Immune System

The researchers reported several notable differences following the retreat.

Brain activity became less pronounced in regions associated with internal mental chatter during meditation. The researchers interpreted this pattern as a sign of more efficient brain function.

Evidence of increased neuroplasticity also emerged in laboratory experiments. When scientists exposed laboratory-grown neurons to blood plasma collected from participants after the retreat, the neurons developed longer branches and formed more connections. These changes are commonly associated with the ability of nerve cells to communicate and adapt.

Metabolism changed as well. Cells exposed to plasma collected after the retreat showed increased glycolytic (sugar-burning) metabolism. Glycolysis is one of the main ways cells convert glucose into usable energy, and the researchers said the shift pointed toward a more flexible and adaptable metabolic state.

The retreat also appeared to activate the body's own pain control mechanisms. Blood concentrations of endogenous opioids increased after the program. Endogenous opioids are naturally produced chemicals that act on some of the same biological systems targeted by opioid pain medications, helping the body regulate pain without an external drug.

Researchers also detected changes in immune signaling. Both inflammatory and anti-inflammatory signals increased at the same time, suggesting that the immune system was undergoing a more complicated adaptive response rather than simply becoming more or less active.

Small RNA molecules and patterns of gene activity in the blood also changed, particularly in biological pathways associated with brain function. Small RNA molecules help control how genes are expressed and can influence the activity of cells throughout the body.

Mystical Experiences and Brain Connectivity

Researchers were also interested in the subjective experiences participants had while meditating.

The volunteers completed the Mystical Experience Questionnaire (MEQ-30), which is designed to measure experiences involving feelings of unity, transcendence, and altered consciousness. Average scores increased significantly, from 2.37 before the retreat to 3.02 afterward.

People who reported stronger mystical experiences also tended to show greater biological changes. In particular, higher questionnaire scores were associated with increased integration of activity between different regions of the brain.

That relationship suggests that greater communication across brain networks may be associated with a stronger likelihood of experiencing profound changes in consciousness.

Similarities to Psychedelic Brain States

One of the most intriguing findings involved patterns of brain activity that resembled effects previously documented in people using psychedelic substances.

The researchers said intensive meditation appeared capable of producing some of the same types of neural connectivity associated with psychedelic experiences, despite participants not taking psychedelic drugs.

"We're seeing the same mystical experiences and neural connectivity patterns that typically require psilocybin, now achieved through meditation practice alone," added Patel. "Seeing both central nervous system changes in brain scans and systemic changes in blood chemistry underscores that these mind-body practices are acting on a whole-body scale."

Psilocybin is the psychoactive compound found in certain psychedelic mushrooms. Researchers have increasingly studied it because it can produce dramatic changes in perception, mood, and the way different brain networks communicate.

The similarities observed in the meditation study do not mean that meditation and psychedelic drugs produce identical effects. Instead, the findings suggest that very different experiences may sometimes engage overlapping brain processes associated with altered states of consciousness.

Possible Implications for Health and Pain

The findings give researchers a potential biological framework for understanding how non-drug mind and body interventions might support health and well-being.

Increased neuroplasticity could potentially support processes involved in mental health, learning, emotional regulation, and resilience to stress. Changes in immune activity could also prove important if future research shows that these effects are reliable and clinically meaningful.

The increase in endogenous opioids is especially interesting for pain research. Because these chemicals are part of the body's built-in pain-regulating system, the researchers said the combination of practices used during the retreat could eventually have implications for chronic pain management.

However, the study was conducted in healthy adults rather than patients with diagnosed medical conditions. Controlled clinical trials will therefore be necessary before researchers can determine whether the observed biological changes translate into meaningful treatment benefits.

The team is particularly interested in studying whether similar retreats could help people living with chronic pain, mood disorders, or conditions involving the immune system.

What Researchers Still Need to Learn

Another major unanswered question is which parts of the retreat were responsible for the observed effects.

Participants experienced several interventions at the same time, including meditation, reconceptualization, and open-label placebo healing. Because those elements were combined, the current study cannot establish how much each individual practice contributed.

Future research will examine the components separately and in different combinations. Scientists also want to determine how long the biological changes last and whether repeating the interventions can strengthen or maintain them over time.

"This study shows that our minds and bodies are deeply interconnected -- what we believe, how we focus our attention, and the practices we participate in can leave measurable fingerprints on our biology," said first author Alex Jinich-Diamant, a doctoral student in the Departments of Cognitive Science and Anesthesiology at UC San Diego. "It's an exciting step toward understanding how conscious experience and physical health are intertwined, and how we might harness that connection to promote well-being in new ways."

Additional coauthors of the study include Sierra Simpson, Juan P. Zuniga-Hertz, Ramamurthy Chitteti, Jan M. Schilling, Jacqueline A. Bonds, Laura Case, Andrei V. Chernov, Natalia Esther Amkie Stahl, Michael Licamele, Narin Fazlalipour and, Swetha Devulapalli, at UC San Diego; Joe Dispenza and Michelle A. Poirier at Metamorphosis LLC; Jacqueline Maree and Tobias Moeller-Bertram at VitaMed Research; and Leonardo Christov-Moore and Nicco Reggente at the Institute for Advanced Consciousness Studies.

The research was supported by the InnerScience Research Fund and a Veterans Administration Research Career Scientist Award (BX005229).

Disclosure: One co-author (Joe Dispenza) is employed by Encephalon, Inc., the company offering the retreat; all other authors declare no competing interests.

Reporting from ScienceDaily contributed to this story.